CDKN2A and melanoma: Among the hypotheses, normal CDKN2A copy number together with loss expression of MTAP could be related to epigenetic mechanism such as MTAP inactivation by promoter hypermethylation, similarly to that described in malignant melanoma by Behrmann et al.35